Innocan Pharma Corporation announced the signing of a wide-scope commercial distribution agreement with Polyflame Europe. As part of the multi-year agreement, Polyflame Europe will enjoy an exclusive right to distribute both of Innocan's SHIR and Relief & Go brands in France based on a purchase forecast of EUR 600,000 per year in the first year and subject to suitable regulation in France. Polyflame built its reputation as a key European player in the import and distribution of regulated products. They have been very active in Europe for the past 48 years, positioning them as one of the major players in their industry.